A Phase II Clinical Trial of Neoadjuvant Chemotherapy With M-VAC Plus Avastin in Patients With Locally Advanced Urothelial Cancer.
Phase of Trial: Phase II
Latest Information Update: 02 Apr 2016
At a glance
- Drugs Bevacizumab (Primary) ; Cisplatin; Doxorubicin; Methotrexate; Vinblastine
- Indications Urogenital cancer
- Focus Biomarker; Therapeutic Use
- 02 Jun 2015 Final results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 26 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 21 Jan 2014 Planned End Date changed from 1 Jun 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov record.